EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of Dihydrocapsaicin on the Metabolism of Efavirenz In Vitro and In Vivo

Bo Wang, Xu Ma, Xinggao Wang, Yuxuan Chen, Quan Zhou, Abdullah Al Mamun iD, Guozhen Wang, Shuanghu Wang iD, Xiaoxin Ma

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Bo Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Lishui Hospital of Wenzhou Medical University, the First Affiliated Hospital of Lishui University, Lishui People's Ho…. Hauptthemen laut MEDLINE: Benzoxazines, Capsaicin, Reverse Transcriptase Inhibitors, Anti-HIV Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: WBE Liver Fibrosis Foundation, City Level Key Research and Development Project of Lishui, Youth Fund of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efavirenz (EFV) is the first‐line treatment for acquired immunodeficiency syndrome. However, capsaicin may affect its properties, although the underlying mechanisms remain unknown. This study aimed to investigate the effects of dihydrocapsaicin (DHC) on the pharmacokinetics of EFV both in vivo and in vitro. Twelve Sprague–Dawley rats were divided into two groups including experimental and control. The experimental group was pretreated with DHC (10 mg/kg/day) for two weeks with 5% sodium carboxymethyl cellulose prior to receiving EFV. After a single‐dose oral administration of 56 mg/kg EFV, blood samples (50 μL) were collected from the caudal vein and analyzed. The effects of DHC on EFV in vitro were further studied in rat liver microsomes (RLMs). The area under the plasma concentration–time curve for EFV increased from 8821.45 ± 2877.31 to 22347.15 ± 7579.96 μg/mL/h ( p < 0.05); the maximum plasma time increased from 2.50 ± 0.84 to 3.50 ± 0.55 h ( p < 0.05) and elimination half‐life increased from 3.13 ± 0.87 to 3.51 ± 0.79 h ( p < 0.05). In contrast, the plasma clearance rate decreased from 6.71 ± 2.48 to 2.65 ± 0.98 L/h/kg ( p < 0.05) in the experimental group compared to that in the control group. Additionally, the results showed that DHC significantly inhibited the metabolism of EFV in RLMs. Drug–drug interactions were observed between DHC and EFV, altering the pharmacokinetics of EFV both in vivo and in vitro. The dosage of capsaicin should be monitored and adjusted in patients receiving EFV maintenance therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzoxazinesCapsaicinReverse Transcriptase InhibitorsAnti-HIV AgentsAnimalsAlkynesCyclopropanesRats, Sprague-DawleyMaleRatsMicrosomes, LiverDrug InteractionsArea Under CurveAdministration, Oral

Stichwörter der Autor:innen

CYP450acquired immunodeficiency syndromedihydrocapsaicindrug–drug interactionpharmacokinetics

Substanzen

AlkynesefavirenzCyclopropanesBenzoxazinesCapsaicindihydrocapsaicinReverse Transcriptase InhibitorsAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Orthopaedics, The Lishui Hospital of Wenzhou Medical University, the First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, China.
  • Department of Pediatric Orthopaedics, Guangxi Zhuang Autonomous Region Maternal and Child Health Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
  • Key Laboratory of Joint Diagnosis and Treatment of Chronic Liver Disease and Liver Cancer of Lishui, Central Laboratory of Lishui Hospital of Wenzhou Medical University, the First Affiliated Hospital of Lishui Universit…
  • Department of Gastroenterology, Shenzhen People's Hospital, the Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.

ORCID-Profile: Abdullah Al Mamun, Shuanghu Wang

Förderung

  • WBE Liver Fibrosis Foundation
  • City Level Key Research and Development Project of Lishui
  • Youth Fund of National Natural Science Foundation of China
  • Medical and Health Research Project of Zhejiang Province

Zitieren

APA

Wang, B., Ma, X., Wang, X., Chen, Y., Zhou, Q., Al Mamun, A., Wang, G., Wang, S., & Ma, X. (2025). Impact of Dihydrocapsaicin on the Metabolism of Efavirenz In Vitro and In Vivo. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70189

Vancouver

Wang B, Ma X, Wang X, Chen Y, Zhou Q, Al Mamun A, et al. Impact of Dihydrocapsaicin on the Metabolism of Efavirenz In Vitro and In Vivo. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70189

BibTeX
@article{Wang2025,
  author = {Wang, Bo and Ma, Xu and Wang, Xinggao and Chen, Yuxuan and Zhou, Quan and Al Mamun, Abdullah and Wang, Guozhen and Wang, Shuanghu and Ma, Xiaoxin},
  title = {Impact of Dihydrocapsaicin on the Metabolism of Efavirenz In Vitro and In Vivo},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70189}
}
Kostenlos starten →